United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69339-172_8bc7e584-a388-43b6-9627-e58b7b79b2d1
- Product NDC
- 69339-172
- Form
- TABLET
- Composition / generic term
- Ondansetron
- Labeler
- Natco Pharma USA LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221024
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (69339-172-01) · 69339-172-01
- 30 TABLET in 1 BOTTLE (69339-172-03) · 69339-172-03
- 500 TABLET in 1 BOTTLE (69339-172-05) · 69339-172-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →